CBNY reports year end net loss of $3.72 million

June 30, 2023

Ciboney Group Limited (CBNY) reported total revenue of $1,000 relative to the $2,000 reported for the prior financial year. No revenue was reported for the quarter (2022: $1,000).

Administrative and general expenses closed the year at $3.72 million, a 20% decline from the $4.62 million recorded in 2022. Within the quarter, the group’s administrative expenses closed at $1.67 million (2022: $562,000).

Loss before taxation closed the period under review at $3.72 million (2022: $4.62 million). While loss before taxation for the quarter amounted to $1.67 million versus a loss of $562,000 for the similar quarter of 2022.

Net loss closed at $3.72 million, 20% less than the loss of $4.62 million for 2022. However, for the quarter, net loss amounted to $1.67 million versus $561,000 booked twelve months earlier.

As such, loss per share (LPS) for the year amounted to $0.680 (2022: $0.847). LPS for the fourth quarter amounted to $0.677 (2022: $0.839). The number of shares used in our calculations is 546,000,000. CBNY last traded on June 30, 2023 at a price of $ 0.89.

Balance Sheet at a Glance:

CBNY posted total assets of $156,000, 96% less than the $3.66 million booked as at May 31, 2022. The decline was mainly attributable to a 96% decline in ‘Income Tax Recoverable’ which closed at $93,000 compared to $2.63 million in the previous comparable year.

Shareholder’s deficit for the year end was $10.62 million relative to the $6.90 million reported last year. As such, shareholder’s deficit per share was $0.019 (2022: shareholders’ deficit per share of $0.013).

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer(s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view(s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2023-06-30T15:19:04-05:00